Extensive regulation of nicotinate phosphoribosyltransferase (NAPRT) expression in human tissues and tumors
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
// Sara Duarte-Pereira 1 , Isabel Pereira-Castro 1,6 , Sarah S. Silva 1 , Mariana Gonçalves Correia 1 , Célia Neto 1 , Luís Teixeira da Costa 1,2 , António Amorim 1,3,4 and Raquel M. Silva 1,5 1 IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal 2 ICAAM - Instituto de Ciências Agrárias e Ambientais Mediterrânicas, University of Évora, Évora, Portugal 3 Faculty of Sciences, University of Porto, Porto, Portugal 4 Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal 5 Institute for Biomedicine - iBiMED & IEETA, University of Aveiro, Aveiro, Portugal 6 Gene Regulation Group, i3S/IBMC - Instituto de Investigação e Inovação em Saúde/Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal Correspondence to: Raquel M. Silva, email: // Keywords : human NAD salvage, NAPRT, NAMPT, alternative transcripts, anti-cancer therapies Received : June 23, 2015 Accepted : November 21, 2015 Published : December 09, 2015 Abstract Nicotinamide adenine dinucleotide (NAD) is a cofactor in redox reactions and a substrate for NAD-consuming enzymes, such as PARPs and sirtuins. As cancer cells have increased NAD requirements, the main NAD salvage enzymes in humans, nicotinamide phosphoribosyltransferase (NAMPT) and nicotinate phosphoribosyltransferase (NAPRT), are involved in the development of novel anti-cancer therapies. Knowledge of the expression patterns of both genes in tissues and tumors is critical for the use of nicotinic acid (NA) as cytoprotective in therapies using NAMPT inhibitors. Herein, we provide a comprehensive study of NAPRT and NAMPT expression across human tissues and tumor cell lines. We show that both genes are widely expressed under normal conditions and describe the occurrence of novel NAPRT transcripts. Also, we explore some of the NAPRT gene expression mechanisms. Our findings underline that the efficiency of NA in treatments with NAMPT inhibitors is dependent on the knowledge of the expression profiles and regulation of both NAMPT and NAPRT .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Annotation of functional variation in personal genomes using RegulomeDB
Boyle, A. P., Hong, E. L., Hariharan, M., Cheng, Y., Schaub, M. A., Kasowski, M., Karczewski, K. J., Park, J., Hitz, B. C., Weng, S., et al. (2012) · Genome Research · doi:10.1101/gr.137323.112 · Cited by 2,722 · cited 1×
“Of note, the NAPRT rs2015562 and rs2305496 variants that are predicted as splicing or gene expression modulators were found in the MKN28 cell line [28, 29].”
Cunningham, F., Amode, M. R., Barrell, D., Beal, K., Billis, K., Brent, S., Carvalho-Silva, D., Clapham, P., Coates, G., Fitzgerald, S., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1010 · Cited by 1,115
Understanding the contribution of synonymous mutations to human disease
Sauna, Z. E., & Kimchi-Sarfaty, C. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3051 · Cited by 1,022 · cited 1×
“Globally, these variants should not be disregarded without further data, as some are predicted to alter splicing sites or gene expression levels, and the effect of coding silent mutations in protein expression or function is increasingly recognized in the context of human disease as well [31-33].”
Database resources of the National Center for Biotechnology Information
Wheeler, D. L., Barrett, T., Benson, D. A., Bryant, S. H., Canese, K., Chetvernin, V., Church, D. M., DiCuccio, M., Edgar, R., Federhen, S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1000 · Cited by 1,007
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.003 · Cited by 911 · cited 1×
“These results are in agreement with previous findings that the main routes to NAD in neurons are the de novo biosynthesis from tryptophan and the NAD salvage from nicotinamide riboside [3, 37, 38].”
The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways
Houtkooper, R. H., Cantó, C., Wanders, R. J., & Auwerx, J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0026 · Cited by 899 · cited 1×
“These results are in agreement with previous findings that the main routes to NAD in neurons are the de novo biosynthesis from tryptophan and the NAD salvage from nicotinamide riboside [3, 37, 38].”
Variation in alternative splicing across human tissues
Yeo, G., Holste, D., Kreiman, G., & Burge, C. B. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r74 · Cited by 584 · cited 1×
“In our study, brain showed the highest number of alternative transcripts, which is supported by previous observations in brain cells, showing over 40% prevalence of alternative splicing [43, 44].”
Watson, M., Roulston, A., Bélec, L., Billot, X., Marcellus, R., Bédard, D., Bernier, C., Branchaud, S., Chan, H., Dairi, K., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00112-09 · Cited by 229
Hara, N., Yamada, K., Shibata, T., Osago, H., Hashimoto, T., & Tsuchiya, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610357200 · Cited by 205 · cited 2×
“Although Nam is the main NAD salvageable precursor in human cells, most likely because this molecule is itself produced in NAD-consuming reactions [2], NA is more efficient in increasing NAD levels, thus, some tissues could preferentially use the NAD salvage pathway from NA [3, 21].”
Buckanovich, R., Yang, Y., & Darnell, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01114.1996 · Cited by 192 · cited 1×
“Among them, is the neuro-oncologic ventral antigen 1 (NOVA-1) protein, a brain specific RBP implicated in neurological disorders [49].”
Cited by
NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism
Xiao, W., Wang, R.-S., Handy, D. E., & Loscalzo, J. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7216 · Cited by 1,061
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Rajman, L., Chwalek, K., & Sinclair, D. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.011 · Cited by 865
NAD+ metabolism, stemness, the immune response, and cancer
Navas, L. E., & Carnero, A. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00354-w · Cited by 517
Braidy, N., Berg, J., Clement, J., Khorshidi, F., Poljak, A., Jayasena, T., Grant, R., & Sachdev, P. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7269 · Cited by 275
Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy
Galli, U., Colombo, G., Travelli, C., Tron, G. C., Genazzani, A. A., & Grolla, A. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00656 · Cited by 162
Metadata
- Authors
- Duarte-Pereira, S., Pereira-Castro, I., Silva, S. S., Correia, M. G., Neto, C., da Costa, L. T., Amorim, A., & Silva, R. M.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-12-09
- Volume
- 7
- Issue
- 2
- Pages
- 1973-1983
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2235472906
- Cited by
- 66
- References
- 13
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Extensive regulation of nicotinate phosphoribosyltransferase (NAPRT) expression in human tissues and tumors. https://app.cochat.ai/papers/10.18632/oncotarget.6538
- The paper
- Duarte-Pereira, S., Pereira-Castro, I., Silva, S. S., Correia, M. G., Neto, C., da Costa, L. T., Amorim, A., & Silva, R. M. (2016). Extensive regulation of nicotinate phosphoribosyltransferase (NAPRT) expression in human tissues and tumors. Oncotarget. https://doi.org/10.18632/oncotarget.6538
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.